ACOG Practice Bulletin No. 141: management of menopausal symptoms
- PMID: 24463691
- DOI: 10.1097/01.AOG.0000441353.20693.78
ACOG Practice Bulletin No. 141: management of menopausal symptoms
Erratum in
-
Practice Bulletin No. 141: Management of Menopausal Symptoms: Correction.Obstet Gynecol. 2016 Jan;127(1):166. doi: 10.1097/AOG.0000000000001230. Obstet Gynecol. 2016. PMID: 27892905 No abstract available.
-
Practice Bulletin No. 141: Management of Menopausal Symptoms: Correction.Obstet Gynecol. 2018 Mar;131(3):604. doi: 10.1097/AOG.0000000000002513. Obstet Gynecol. 2018. PMID: 29470333 No abstract available.
Abstract
Vasomotor and vaginal symptoms are cardinal symptoms of menopause. Vasomotor symptoms can be particularly troubling to women and are the most commonly reported menopausal symptoms, with a reported prevalence of 50-82% among U.S. women who experience natural menopause (1, 2). The occurrence of vasomotor symptoms increases during the transition to menopause and peaks approximately 1 year after the final menstrual period (3-5). The purpose of this document is to provide evidence-based guidelines for the treatment of vasomotor and vaginal symptoms related to natural and surgical menopause. (Treatment of menopausal symptoms in cancer survivors is discussed in the American College of Obstetricians and Gynecologists' Practice Bulletin Number 126, Management of Gynecologic Issues in Women With Breast Cancer.).
Similar articles
-
Hormone Therapy and Other Treatments for Symptoms of Menopause.Am Fam Physician. 2016 Dec 1;94(11):884-889. Am Fam Physician. 2016. PMID: 27929271 Review.
-
Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.Breast Cancer. 2017 Jul;24(4):528-534. doi: 10.1007/s12282-016-0735-y. Epub 2016 Oct 12. Breast Cancer. 2017. PMID: 27730528
-
Tissue-selective estrogen complexes for postmenopausal women.Maturitas. 2013 Nov;76(3):213-20. doi: 10.1016/j.maturitas.2013.06.003. Epub 2013 Jul 11. Maturitas. 2013. PMID: 23849704 Review.
-
Approach to the patient with menopausal symptoms.J Clin Endocrinol Metab. 2008 Dec;93(12):4567-75. doi: 10.1210/jc.2008-1272. J Clin Endocrinol Metab. 2008. PMID: 19056840
-
Clinical practice. Management of menopausal symptoms.N Engl J Med. 2006 Nov 30;355(22):2338-47. doi: 10.1056/NEJMcp054015. N Engl J Med. 2006. PMID: 17135587 Review. No abstract available.
Cited by
-
Menopausal Hormone Therapy Use Among Postmenopausal Women.JAMA Health Forum. 2024 Sep 6;5(9):e243128. doi: 10.1001/jamahealthforum.2024.3128. JAMA Health Forum. 2024. PMID: 39331372 Free PMC article.
-
Treatment satisfaction, unmet needs, and new treatment expectations for vasomotor symptoms due to menopause: women's and physicians' opinions.Menopause. 2024 Sep 1;31(9):769-780. doi: 10.1097/GME.0000000000002399. Menopause. 2024. PMID: 39186452 Free PMC article.
-
Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I).J Int Med Res. 2024 May;52(5):3000605241247684. doi: 10.1177/03000605241247684. J Int Med Res. 2024. PMID: 38818888 Free PMC article. Clinical Trial.
-
Multimodal, Technology-Assisted Intervention for the Management of Menopause after Cancer Improves Cancer-Related Quality of Life-Results from the Menopause after Cancer (Mac) Study.Cancers (Basel). 2024 Mar 12;16(6):1127. doi: 10.3390/cancers16061127. Cancers (Basel). 2024. PMID: 38539462 Free PMC article.
-
Role of Platelet-Rich Plasma in Genitourinary Syndrome of Menopause.Cureus. 2024 Jan 31;16(1):e53316. doi: 10.7759/cureus.53316. eCollection 2024 Jan. Cureus. 2024. PMID: 38435897 Free PMC article. Review.
References
-
- Feldman BM, Voda A, Gronseth E. The prevalence of hot flash and associated variables among perimenopausal women. Res Nurs Health 1985;8:261–8.
-
- McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103–15.
-
- Gold EB, Colvin A, Avis N, Bromberger J, Greendale GA, Powell L, et al.. Longitudinal analysis of the association between vasomotor symptoms and race/ ethnicity across the menopausal transition: study of women’s health across the nation. Am J Public Health 2006;96:122–35.
-
- Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, et al.. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463–73.
-
- Politi MC, Schleinitz MD, Col NF. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med 2008;23:1507–13.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
